Menu
  • Join
  • Login
  • Contact
 

Search abstracts


Current status & Strategies required for the development of Orphan drug

  • At: 2012 FIP Congress in Amsterdam (the Netherlands)
  • Type: Poster
  • By: PANDEY, Abhishek (Gurukul Institute of Pharmaceutical Science & Research, Pharmaceutics, Gwalior, India)
  • Co-author(s): Bhadouria, V. (Gurukul Institute of Pharmaceutical Science & Research, Gwalior, India)
    Darbari, S. (Gurukul Institute of Pharmaceutical Science & Research, Gwalior, India)
    Sharma, V. (Gurukul Institute of Pharmaceutical Science & Research, Gwalior, India)
  • Abstract:

    The aim of this investigation about highlight the protocol, promotion and strategies to be followed in order to develop the orphan drug for the treatment of rare disease. There are many diseases and conditions, such asHuntingtondiseases, myoclonus and muscular dystrophy which affect small numbers of individuals. Drugs for theses diseases and

    ..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses